Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
https://link.springer.com/content/pdf/10.1007/s10620-020-06630-7.pdf
Reference26 articles.
1. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231.
2. Schierwagen R, Uschner FE, Magdaleno F, et al. Rationale for the use of statins in liver disease. Am J Physiol Gastrointest Liver Physiol. 2017;312:G407-G412.
3. Kalaitzakis E, Rosengren A, Skommevik T, et al. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci. 2010;55:467-475. https://doi.org/10.1007/s10620-009-0738-z
4. Wehmeyer MH, Heuer AJ, Benten D, et al. High rate of cardiac abnormalities in a postmortem analysis of patients suffering from liver cirrhosis. J Clin Gastroenterol. 2015;49:866-872.
5. Danielsen KV, Wiese S, Hove J, et al. Pronounced coronary arteriosclerosis in cirrhosis: Influence on cardiac function and survival? Dig Dis Sci. 2018;63:1355-1362. https://doi.org/10.1007/s10620-018-5006-7
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC;Hepatology;2024-03-11
2. Letter to the Editor: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC;Hepatology;2024-03-11
3. Role of liver sinusoidal endothelial cells in the diagnosis and treatment of liver diseases;Sinusoidal Cells in Liver Diseases;2024
4. Statins in Cirrhosis: Trial Data Are in but the Jury Is Still Out;Digestive Diseases and Sciences;2023-05-22
5. Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients;Digestive Diseases and Sciences;2023-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3